Morgan Stanley’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$91.8M Buy
1,751,882
+15,791
+0.9% +$617K ﹤0.01% 1645
2026
Q1
$61.4M Sell
1,736,091
-152,396
-8% -$4.73M ﹤0.01% 1893
2025
Q4
$52.8M Buy
1,888,487
+336,988
+22% +$10.1M ﹤0.01% 2028
2025
Q3
$46.5M Sell
1,551,499
-250,553
-14% -$7.06M ﹤0.01% 2071
2025
Q2
$51.6M Sell
1,802,052
-361,547
-17% -$10.8M ﹤0.01% 1906
2025
Q1
$71.4M Buy
2,163,599
+344,604
+19% +$11.2M 0.01% 1500
2024
Q4
$52.3M Sell
1,818,995
-750,338
-29% -$21.6M ﹤0.01% 1800
2024
Q3
$71.9M Buy
2,569,333
+453,741
+21% +$12.1M 0.01% 1508
2024
Q2
$51M Buy
2,115,592
+162,145
+8% +$3.98M ﹤0.01% 1737
2024
Q1
$52.9M Sell
1,953,447
-565,168
-22% -$16.1M ﹤0.01% 1705
2023
Q4
$69.9M Buy
2,518,615
+505,823
+25% +$13.1M 0.01% 1401
2023
Q3
$56.4M Buy
2,012,792
+891,641
+80% +$26.1M 0.01% 1454
2023
Q2
$35.1M Buy
1,121,151
+546,580
+95% +$16.5M ﹤0.01% 1917
2023
Q1
$16.2M Sell
574,571
-277,262
-33% -$7.55M ﹤0.01% 2653
2022
Q4
$22.3M Buy
851,833
+81,812
+11% +$1.96M ﹤0.01% 2233
2022
Q3
$17.2M Buy
770,021
+22,661
+3% +$589K ﹤0.01% 2368
2022
Q2
$22.3M Sell
747,360
-840,979
-53% -$24.2M ﹤0.01% 2170
2022
Q1
$41.8M Buy
1,588,339
+1,194,845
+304% +$29.6M 0.01% 1430
2021
Q4
$9.15M Sell
393,494
-23,642
-6% -$622K ﹤0.01% 3037
2021
Q3
$12.9M Sell
417,136
-448,914
-52% -$12.7M ﹤0.01% 2601
2021
Q2
$21.2M Buy
866,050
+325,610
+60% +$7.24M ﹤0.01% 2080
2021
Q1
$10.1M Sell
540,440
-9,679
-2% -$198K ﹤0.01% 2637
2020
Q4
$11M Buy
550,119
+210,117
+62% +$3.85M ﹤0.01% 2409
2020
Q3
$5.63M Buy
340,002
+274,588
+420% +$4.99M ﹤0.01% 2601
2020
Q2
$1.27M Sell
65,414
-388,758
-86% -$6.31M ﹤0.01% 3981
2020
Q1
$6.55M Sell
454,172
-26,336
-5% -$470K ﹤0.01% 2194
2019
Q4
$9.8M Buy
480,508
+5,136
+1% +$102K ﹤0.01% 2454
2019
Q3
$9.27M Buy
475,372
+353,203
+289% +$7.68M ﹤0.01% 2212
2019
Q2
$2.75M Buy
122,169
+55,894
+84% +$1.53M ﹤0.01% 3507
2019
Q1
$2.42M Sell
66,275
-45,188
-41% -$1.49M ﹤0.01% 3423
2018
Q4
$3.29M Buy
111,463
+69,747
+167% +$2.57M ﹤0.01% 3343
2018
Q3
$1.77M Sell
41,716
-17,472
-30% -$758K ﹤0.01% 4100
2018
Q2
$2.44M Sell
59,188
-19,290
-25% -$879K ﹤0.01% 3886
2018
Q1
$4.55M Buy
78,478
+20,897
+36% +$1.22M ﹤0.01% 3124
2017
Q4
$3.15M Sell
57,581
-11,582
-17% -$591K ﹤0.01% 3592
2017
Q3
$3.52M Buy
69,163
+16,032
+30% +$857K ﹤0.01% 3332
2017
Q2
$3.08M Sell
53,131
-19,700
-27% -$1.14M ﹤0.01% 3370
2017
Q1
$4.26M Sell
72,831
-33,548
-32% -$1.9M ﹤0.01% 3020
2016
Q4
$5.91M Sell
106,379
-13,053
-11% -$698K ﹤0.01% 2823
2016
Q3
$5.62M Buy
119,432
+76,650
+179% +$3.64M ﹤0.01% 2552
2016
Q2
$1.85M Sell
42,782
-41,878
-49% -$1.73M ﹤0.01% 3492
2016
Q1
$2.89M Sell
84,660
-194,159
-70% -$7.67M ﹤0.01% 3030
2015
Q4
$22.1M Buy
278,819
+132,076
+90% +$9.25M 0.01% 1329
2015
Q3
$8.61M Sell
146,743
-43,635
-23% -$2.88M ﹤0.01% 2116
2015
Q2
$12.2M Sell
190,378
-22,346
-11% -$1.37M ﹤0.01% 1907
2015
Q1
$13M Buy
212,724
+34,597
+19% +$2.36M ﹤0.01% 1804
2014
Q4
$10.4M Sell
178,127
-44,895
-20% -$2.29M ﹤0.01% 2024
2014
Q3
$9.56M Sell
223,022
-112,108
-33% -$5.03M ﹤0.01% 2059
2014
Q2
$16.9M Buy
335,130
+806
+0.2% +$37.2K 0.01% 1569
2014
Q1
$14.7M Sell
334,324
-12,927
-4% -$615K 0.01% 1634
2013
Q4
$14.1M Sell
347,251
-209,944
-38% -$7.75M 0.01% 1632
2013
Q3
$18.7M Sell
557,195
-97,295
-15% -$3.17M 0.01% 1273
2013
Q2
$18.8M Buy
+654,490
New +$19.1M 0.01% 1226

Other funds holding ALKS

Morgan Stanley's ALKS Position: Q2 2026 in Review

Morgan Stanley increased its Alkermes (ALKS) stake by 0.91% in Q2 2026, buying an estimated $617K and bringing the position to 1,751,882 shares worth $91.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1645.

Morgan Stanley first reported a position in ALKS in Q2 2013 and has held it in 53 quarters since. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Morgan Stanley held 1,751,882 shares of Alkermes worth $91.8M as of Q2 2026.
  • Morgan Stanley bought 15,791 Alkermes shares in Q2 2026, an estimated $617K.
  • Alkermes made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #1645 holding.
  • Morgan Stanley first reported a position in Alkermes in Q2 2013 and has held it in 53 quarters since.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.